Article Versions Notes

Salama BM, Helmy MW, Fouad H, Shamaa MM, Houssen ME. The Synergistic Antitumor Effect of Decitabine and Vorinostat Combination on HepG2 Human Hepatocellular Carcinoma Cell Line via Epigenetic Modulation of Autophagy–Apoptosis Molecular Crosstalk. Current Issues in Molecular Biology. 2023; 45(7):5935-5949. https://doi.org/10.3390/cimb45070375

Salama, Basant M., Maged W. Helmy, Hosny Fouad, Marium M. Shamaa, and Maha E. Houssen. 2023. "The Synergistic Antitumor Effect of Decitabine and Vorinostat Combination on HepG2 Human Hepatocellular Carcinoma Cell Line via Epigenetic Modulation of Autophagy–Apoptosis Molecular Crosstalk" Current Issues in Molecular Biology 45, no. 7: 5935-5949. https://doi.org/10.3390/cimb45070375

Salama, B. M., Helmy, M. W., Fouad, H., Shamaa, M. M., & Houssen, M. E. (2023). The Synergistic Antitumor Effect of Decitabine and Vorinostat Combination on HepG2 Human Hepatocellular Carcinoma Cell Line via Epigenetic Modulation of Autophagy–Apoptosis Molecular Crosstalk. Current Issues in Molecular Biology, 45(7), 5935-5949. https://doi.org/10.3390/cimb45070375